• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Steady-state extrarenal sorbitol clearance as a measure of hepatic plasma flow.

作者信息

Zeeh J, Lange H, Bosch J, Pohl S, Loesgen H, Eggers R, Navasa M, Chesta J, Bircher J

机构信息

Division of Clinical Pharmacology, University of Goettingen, Federal Republic of Germany.

出版信息

Gastroenterology. 1988 Sep;95(3):749-59. doi: 10.1016/s0016-5085(88)80024-6.

DOI:10.1016/s0016-5085(88)80024-6
PMID:3396820
Abstract

Hepatic plasma flow was assessed with sorbitol (hepatic extraction = 0.96) at steady state. After infusion of 50 mg/min for 3 h, total and renal sorbitol clearances were calculated, and the extrarenal clearance was obtained by taking the difference between the two. In normal volunteers, the mean (+/- SD) extrarenal sorbitol clearance was 10.6 +/- 2.1 ml/min.kg. In patients with various liver diseases, it was correlated more closely to the fractional clearance of indocyanine green (r = 0.83, n = 57) than the galactose elimination capacity (r = 0.66, n = 55). Hepatic vein catheterization showed that the hepatic extraction of sorbitol was always much higher than the extraction of indocyanine green; there was no evidence for extrahepatic, extrarenal sorbitol elimination. On the basis of these findings, sorbitol is kinetically superior to indocyanine green and, although the noninvasively determined extrarenal sorbitol clearance at steady state may not be equal to total hepatic plasma flow, it may at least be regarded as a measure of parenchymal liver plasma flow.

摘要

相似文献

1
Steady-state extrarenal sorbitol clearance as a measure of hepatic plasma flow.
Gastroenterology. 1988 Sep;95(3):749-59. doi: 10.1016/s0016-5085(88)80024-6.
2
Sorbitol as a test substance for measurement of liver plasma flow in humans.
Hepatology. 1998 Jul;28(1):50-6. doi: 10.1002/hep.510280109.
3
Combined evaluation of total and functional liver plasma flows and intrahepatic shunting.肝脏总血浆流量、功能性血浆流量及肝内分流的联合评估
Dig Dis Sci. 1991 Sep;36(9):1189-96. doi: 10.1007/BF01307507.
4
Hepatic clearances of antipyrine, indocyanine green, and galactose in normal subjects and in patients with chronic liver diseases.
Clin Pharmacol Ther. 1988 Aug;44(2):217-24. doi: 10.1038/clpt.1988.140.
5
Extrarenal sorbitol clearance after liver transplantation.肝移植术后肾外山梨醇清除率
Therapie. 1992 Jan-Feb;47(1):47-51.
6
Assessment of the hepatic circulation in humans: new concepts based on evidence derived from a D-sorbitol clearance method.人体肝循环的评估:基于D-山梨醇清除率法证据的新概念
J Lab Clin Med. 1998 May;131(5):393-405. doi: 10.1016/s0022-2143(98)90139-1.
7
Noninvasive functional liver blood flow measurement: comparison between bolus dose and steady-state clearance of sorbitol in a small-rodent model.非侵入性功能性肝血流测量:在小型啮齿动物模型中,山梨醇的单次剂量与稳态清除率的比较。
Am J Physiol Gastrointest Liver Physiol. 2010 Feb;298(2):G177-81. doi: 10.1152/ajpgi.90688.2008. Epub 2009 Nov 25.
8
Hepatic plasma flow estimated according to Fick's principle in patients with hepatic encephalopathy: evaluation of indocyanine green and D-sorbitol as test substances.根据菲克原理估算肝性脑病患者的肝血浆流量:评价吲哚菁绿和D-山梨醇作为测试物质的情况。
Hepatology. 1998 Mar;27(3):666-73. doi: 10.1002/hep.510270305.
9
Interpretation of simultaneous measurements of hepatic extraction fractions of indocyanine green and sorbitol: evidence of hepatic shunts and capillarization?吲哚菁绿和山梨醇肝提取分数同步测量的解读:肝内分流和毛细血管化的证据?
Dig Dis Sci. 2000 Feb;45(2):359-65. doi: 10.1023/a:1005476913311.
10
Rapid determination of functional liver plasma flow in ICU patients by a modified hepatic D-sorbitol plasma clearance method.通过改良的肝 D-山梨醇血浆清除率法快速测定重症监护病房患者的功能性肝血浆流量。
Eur J Drug Metab Pharmacokinet. 1993 Oct-Dec;18(4):327-31. doi: 10.1007/BF03190181.

引用本文的文献

1
A Nomogram Based on Preoperative Lab Tests, BMI, ICG-R15, and EHBF for the Prediction of Post-Hepatectomy Liver Failure in Patients with Hepatocellular Carcinoma.基于术前实验室检查、BMI、ICG-R15和EHBF的列线图预测肝细胞癌患者肝切除术后肝衰竭
J Clin Med. 2022 Dec 31;12(1):324. doi: 10.3390/jcm12010324.
2
Sources of Interindividual Variability.个体间差异的来源。
Methods Mol Biol. 2021;2342:481-550. doi: 10.1007/978-1-0716-1554-6_17.
3
Comparison of Changes in Biochemical Markers for Skeletal Muscles, Hepatic Metabolism, and Renal Function after Three Types of Long-distance Running: Observational Study.
三种长跑后骨骼肌、肝脏代谢及肾功能生化标志物变化的比较:观察性研究
Medicine (Baltimore). 2016 May;95(20):e3657. doi: 10.1097/MD.0000000000003657.
4
Noninvasive assessment of liver function.肝功能的无创评估。
Curr Opin Gastroenterol. 2015 May;31(3):199-208. doi: 10.1097/MOG.0000000000000167.
5
Assessment of the hepatic microvascular changes in liver cirrhosis by perfusion computed tomography.通过灌注计算机断层扫描评估肝硬化肝脏的微血管变化
World J Gastroenterol. 2009 Jul 28;15(28):3532-7. doi: 10.3748/wjg.15.3532.
6
Pharmacokinetics and dosage adjustment in patients with hepatic dysfunction.肝功能不全患者的药代动力学及剂量调整
Eur J Clin Pharmacol. 2008 Dec;64(12):1147-61. doi: 10.1007/s00228-008-0553-z. Epub 2008 Sep 2.
7
Pilot study on the influence of liver blood flow and cardiac output on the clearance of propofol in critically ill patients.肝血流和心输出量对重症患者丙泊酚清除率影响的初步研究。
Eur J Clin Pharmacol. 2008 Mar;64(3):329-34. doi: 10.1007/s00228-007-0399-9. Epub 2007 Nov 13.
8
Quantitative tissue blood flow measurement of the liver parenchyma: comparison between xenon CT and perfusion CT.肝脏实质组织血流量的定量测量:氙CT与灌注CT的比较。
Dig Dis Sci. 2007 Apr;52(4):943-9. doi: 10.1007/s10620-006-9327-6. Epub 2007 Feb 23.
9
Improvement of quantitative testing of liver function in patients with chronic hepatitis C after installment of antiviral therapy.慢性丙型肝炎患者抗病毒治疗后肝功能定量检测的改善
World J Gastroenterol. 2005 Sep 21;11(35):5521-4. doi: 10.3748/wjg.v11.i35.5521.
10
Dose adjustment in patients with liver disease.肝病患者的剂量调整。
Drug Saf. 2005;28(6):529-45. doi: 10.2165/00002018-200528060-00005.